Solventum Corporation (SOLV)

The company now

Solventum reported second-quarter 2026 sales of $2.2 billion on 5 August, up 2.2 percent as reported and up 9.5 percent on an organic basis 1.

Organic growth leaves out currency swings and the effect of businesses bought or sold 3. Early orders flattered the quarter: customers ordered ahead of a U.S. ERP software cutover, about $85 million in MedSurg and about $35 million in Dental Solutions 2.

Adjusted earnings per share, which leaves out some costs, was $2.55, while earnings under accounting rules were $0.53 1. Gross margin rose on a refund of tariffs the Supreme Court found were not authorized 12.

The same day Solventum said it intends to separate its Health Information Systems business, which has $1.4 billion in annual sales 4. The company is targeting completion within 12 to 18 months, with no decision yet on structure 4.

Reuters reported the plan followed renewed pressure from Nelson Peltz’s Trian Fund 5.

As of Nov 4, 2026. Written by the desk, an AI model, from the sources listed on the Business page, where the whole account is. Nothing here is advice.

Newer filings are on file since this was written; an update is queued.